SANUWAVE Health, Inc. (SNWV)

From the record

SANUWAVE Health, Inc.'s filings since 2017 show 23 warning events of 5 kinds: a debt default or acceleration notice (8-K item 2.04, 2 times, the latest 2019-01-25); a notice about its exchange listing (8-K item 3.01, 3 times, the latest 2026-09-25); a warning not to rely on past financial statements (8-K item 4.02, 3 times, the latest 2026-03-13); an auditor change (8-K item 4.01, 5 times, the latest 2025-05-21); a late-report notice (Form NT 10-K or NT 10-Q, 10 times, the latest 2022-05-16) (its current reports).

From the record

SANUWAVE Health, Inc.'s 10 filed years say what it did: revenue went from $1 million in fiscal 2016 to $44 million in fiscal 2025, up 47% a year; it rose in 7 of 9 years; the deepest fall was 46% from fiscal 2016 to fiscal 2017; net income was positive in 1 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, SANUWAVE Health, Inc.'s diluted share count grew about 83.7% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 10 sales and 0 purchases of their own stock on the open market in the year to 2026-10-02 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, SANUWAVE Health, Inc. earned about 730 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 91 cents per dollar of everything the company owns. Leverage: it owed about 96 cents per dollar of assets, and net share issuance: its share count grew 103.5% over the year (the filed statements).

From the record

SANUWAVE Health, Inc.'s standing among 109 graded names in its industry family: revenue of $44 million in fiscal 2025 ranks in the bottom 40% by size; a net margin of 26.8% ranks in the top 5%; revenue growth of 38% a year over the last 3 filed years ranks in the top 20% (its annual reports).

From the record

SANUWAVE Health, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Frank, Morgan C. (Chief Executive Officer, as filed), filing under that title since 2026-01-06, 10 months (bottom 18% of its family); the 8 officers and directors filing in the last fifteen months have been on the record a median of 2.5 years (bottom 10%); 12 officer or director changes were reported on Form 8-K since 2023-11-13, against the 8 people in charge now (bottom 7%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

SANUWAVE Health, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $12 million against debt of $22 million leaves -26.6% of its assets as net cash, bottom 10% of its family; cash from operations less capital spending is 4.4% of revenue (top 31%); a gross margin of 77.1% (top 16%); research spending of 3.1% of revenue (bottom 13%) (its annual report).

From the record

SANUWAVE Health, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 38% a year over the last three filed years against 47% over all 10, slowing (bottom 30% of its family); the newest year grew 35% (top 19%); research spending grew 33.6% a year (top 12%); capital spending grew 38.4% a year (top 12%) (its annual reports). SANUWAVE Health, Inc. reported 5 product lines in fiscal 2025: Consumables Parts and Accessories Revenue at $26 million (59%), System Revenue at $18 million (41%), Other Revenue at $206 thousand (1%), and 2 more; 3 of 5 grew against the year before (its annual report).

From the record

SANUWAVE Health, Inc.'s newest year against its own record: revenue of $44 million in fiscal 2025 came in 3.3% below the $46 million its prior three years' pace pointed to (bottom 49% of its family); net income of $12 million against a prior three-year average of $23 million (top 8%); a net margin of 26.8% against -96.5% before (top 13%) (its annual reports).